Corey S. Cutler, MD, MPH, FRCPC
Advertisement
Corey Cutler, MD, MPH, FRCPC, is the director of the Adult Stem Cell Transplantation Program, director of Clinical Research Stem Cell Transplantation, and director of Stem Cell Transplantation Survivorship Program Institute at Dana-Farber Cancer Institute.
Articles by Corey S. Cutler, MD, MPH, FRCPC
Corey S. Cutler, MD, MPH, FRCPC, provides insight on the case of a 49-year-old man with chronic GVHD and reviews current and emerging treatment options for disease management.
Corey S. Cutler, MD, MPH, discusses the current treatment options for patients with chronic graft-versus-host-disease and highlighted some upcoming research.
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Alpelisib/Fulvestrant Improves PFS in Post-CDK4/6 HR+/HER2- Breast Cancer
2
Gedatolisib Improves PFS in HR+/HER2-/PIK3CA-WT Advanced Breast Cancer
3
FDA Approves Niraparib/Abiraterone Combo for BRCA2-Mutated mCSPC
4
Nadunolimab Misses Efficacy Mark in TNBC, Despite Strong OS
5
